PPT-Early Laboratory markers of Bone disease in CKD

Author : brown | Published Date : 2022-02-24

Lowell DilworthChemical Pathologist CKD CKD and Bone disease Mineral metabolism controlled by kidneys intestine parathyroid glands and bone The kidney plays

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Early Laboratory markers of Bone disease..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Early Laboratory markers of Bone disease in CKD: Transcript


Lowell DilworthChemical Pathologist CKD CKD and Bone disease Mineral metabolism controlled by kidneys intestine parathyroid glands and bone The kidney plays a critical role in mineral homeostasis regulation and therefore renal disease exerts widespread effects on the skeleton and soft . Pro: Andy Stein. Con: Dan Ford. Chair: Prof. Higgins. Tuesday, 5. th. November 2013, 1-2pm. CSB Room 00067. The expanding definition of CKD is unnecessarily labelling many people as diseased: Summary. Program Goals. Hepcidin in Chronic Kidney Disease. Treatment of Iron Deficiency Anemia. Assessment of IV Iron in Patients With Non-Dialysis-Dependent CKD. DOPPS Study. Ferric Pyrophosphate. Phosphate Binders. Kevin Harley, M.D.. Assistant Clinical Professor. Department of Medicine. Division of Nephrology & Hypertension. UC Irvine Medical Center. Objectives. Review Definition of CKD and its classification. 1 Table 1.1 Distribution of NHANES participants with diabetes, self-reported cardiovascular disease, & single sample markers of CKD, 2007-2012. Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, 1999-2004 & 2005–2012 participants age 20 & older. Note: Cardiovascular disease designation is based on self-report of any CVD condition (see CKD Analytical Methods chapter for detail); CKD is defined as eGFR <60 or ACR ≥30. Abbreviations: ACR, urine albumin/creatinine ratio; CKD, chronic kidney disease; SR CVD, self-reported cardiovascular disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; . not applicable.. Learning Objectives. Utilize appropriate screening tools, such as GFR and ACR, in order to diagnose and monitor CKD patients.. Classify CKD, based on GFR and albuminuria categories, in order to guide appropriate treatment. . in Asia Pacific . Dato’ Dr Lee Joon-Kiong. Deputy Medical Director. HOD, Department of Orthopedic Surgery. Beacon Hospital, Malaysia. Disclaimer. No conflict of interest to be declared. Outline. Part 1. Definition of CKD. Staging of CKD. Etiology of CKD. How to measure Kidney function . Incidence of ESRD. (per million population, 1990, by HSA, unadjusted). USRDS, 2000. Incidence of ESRD. (per million population, 2000, by HSA, unadjusted) . KDIGO 2017 Clinical Practice Guideline Update. Speaker’s Guide. Summary of KDIGO CKD-MBD Guideline Recommendations. This Speaker’s Guide combines the new recommendation statements . (noted in green) . Namita Singh, MD, FASN. Year 2021. DISCLOSURES. I have no financial relationships with commercial interests to disclose.. This presentation does not include discussion of off-label or investigational use. . Hyperkalemia, Metabolic Acidosis, Malnutrition, Depression & Acute Kidney Injury. Andrew . Narva. , MD, FASN & . Amy Barton . Pai. , PharmD, MHI, FASN, FCCP, FNKF. Andrew . Narva. , MD, FASN. In CKD and HD patients dysfunction of . immu. ne . sy. stem . a. lterations. . belonge. to . . involv. ing. . i. nnate. and . a. daptive. . i. mmunity. in T and B lymphocytes (. Reduced . T regulatory cells and memory cells and increased innate cells). . .. สุดารัตน์ . ศุภ. กิจเจริญ. หน่วยงานวิสัญญี โรงพยาบาลกำแพงเพชร. Etiology of CKD. In UK , most common causes are;. Kidney Specialists, Inc.. National Kidney Foundation of Central Ohio. Board of Advisors. Medical Advisory Board. Goals of this talk:. Teach providers how to evaluate CKD patients in their office, to start the diagnostic and treatment plan. By. Mostafa. . Abd_Elsalam,MD. MUH,MNDU. Definitions. K/DOQI, 2002. Chronic kidney disease . Epidemiology of chronic kidney disease. . U.S. Renal Data System (2013) USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease.

Download Document

Here is the link to download the presentation.
"Early Laboratory markers of Bone disease in CKD"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents